BI Shanghai Renews Pact With Sinopharm To Quadruple China Sales
This article was originally published in PharmAsia News
Executive Summary
Boehringer Ingelheim's China arm renewed its lucrative distribution agreement with Sinopharm Medicine Holding. Boehringer Ingelheim Shanghai Pharmaceuticals said its Chinese sales are expected to more than quadruple in the period between 2006, the year before the agreement was initiated, and 2012. In 2007, BI Shanghai signed a one-year agreement giving Sinopharm its first distribution deal with a foreign company, while making BI the first foreign drug maker to give a Chinese company full distribution rights for all of its products. The renewal extends the agreement through the end of 2009. (Click here for more